 |
|
|
| |
Five-Years of Continuous Entecavir for Nucleoside-Naive HBeAg(+) Chronic Hepatitis B: Results from Studies ETV-022/-901
|
| |
| |
Reported by Jules Levin
13th ISVHLD March 20-24 2009 Wash DC
S Han1, TT Chang2, YC Chao3, SK Yoon4, RG Gish5, H Cheinquer6, GE Kitis7,
H Zhang8 and U Iloeje8
1. Division of Digestive Disease, UCLA School Of Medicine, LA, California, USA; 2. Department of Internal Medicine, National Cheng Kung University Medical
College, Tainan, Taiwan; 3. Neuro-Medical Scientific Center Departments, Buddhist Tzu Chi General Hospital, Taipei Branch, Taipei, Taiwan; 4. Kangnam St. Mary's Hospital, Seoul, Korea; 5. Division of Hepatology and Complex GI, California Pacific Medical Center, San Francisco, California, USA; 6. Universidade
Federal Do Rio Grande Do Sul, Porto Alegre, Brazil; 7. Department of Gastroenterology, Georgios Papanikolaou Hospital, Thessaloniki, Greece; 8. Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, USA
|
| |
|
|
|
|
|
